NS Pharma Parent Company, Nippon Shinyaku, Exercises Option Rights for Commercialization of AB2 BIO’s Tadekinig alfa in the U.S.
PARAMUS, N.J., July 30, 2026 /PRNewswire/ — NS Pharma, Inc. (Headquarters: Paramus, New Jersey; President: Yukiteru Sugiyama) announced…